HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

AbstractBACKGROUND:
Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography and the benefit of its pharmacological treatment is unclear. Although prophylactic use of gabexate for the reduction of pancreatic injury after ERCP has been evaluated, the discrepancy about gabexate's beneficial effect on pancreatic injury still exists. This study aimed to evaluate the effectiveness and safety of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP).
METHODS:
We employed the method recommended by the Cochrane Collaboration to perform a meta-analysis of randomized controlled trials (RCTs) of gabexate in the prevention of post-ERCP pancreatitis (PEP) including three RCTs conducted in Italy and one in China.
RESULTS:
All of the four RCTs were of high quality. When the RCTs were analyzed, odds ratios (OR) for gabexate mesilate were 0.67 [95% CI (0.31 to approximately 1.47), p = 0.32] for PEP, 3.78 [95% CI (0.62 to approximately 22.98), p = 0.15] for severe PEP, 0.68 [95% CI (0.19 to approximately 2.43), p = 0.56] for the case-fatality of PEP, 0.88 [95% CI (0.72 to approximately 1.07), p = 0.20] for post-ERCP hyperamylasemia, 0.69 [95% CI (0.39 to approximately 1.21), p = 0.19] for post-ERCP abdominal pain, thus indicating no beneficial effects of gabexate on acute pancreatitis, the death rate of PEP, hyperamylasemia and abdominal pain. No evidence of publication bias was found.
CONCLUSION:
Gabexate mesilate can not prevent the pancreatic injury after ERCP. It is not recommended for the use of gabexate mesilate in the prophylaxis of PEP.
AuthorsMinghua Zheng, Yongping Chen, Xinjun Yang, Ji Li, Youcai Zhang, Qiqiang Zeng
JournalBMC gastroenterology (BMC Gastroenterol) Vol. 7 Pg. 6 ( 2007) ISSN: 1471-230X [Electronic] England
PMID17295917 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Serine Proteinase Inhibitors
  • Gabexate
Topics
  • Acute Disease
  • Cholangiopancreatography, Endoscopic Retrograde (adverse effects)
  • Gabexate (adverse effects, therapeutic use)
  • Humans
  • Linear Models
  • Odds Ratio
  • Pancreatitis (etiology, prevention & control)
  • Postoperative Complications (prevention & control)
  • Premedication
  • Randomized Controlled Trials as Topic
  • Serine Proteinase Inhibitors (adverse effects, therapeutic use)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: